LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Fedratinib | 1.11 | uM | LJP5 | 72 | hr | 1694 | 9912 | 11103 | 0.8928 | 0.9180 |
MCF 10A | Fedratinib | 3.33 | uM | LJP5 | 72 | hr | 1694 | 7024 | 11103 | 0.6325 | 0.6889 |
MCF 10A | Fedratinib | 10 | uM | LJP5 | 72 | hr | 1694 | 2149 | 11103 | 0.1936 | 0.0906 |
MCF 10A | Trametinib | 0.04 | uM | LJP5 | 72 | hr | 1694 | 2756 | 11103 | 0.2482 | 0.1961 |
MCF 10A | Trametinib | 0.12 | uM | LJP5 | 72 | hr | 1694 | 2983 | 11103 | 0.2688 | 0.2317 |
MCF 10A | Trametinib | 0.37 | uM | LJP5 | 72 | hr | 1694 | 3044 | 11103 | 0.2743 | 0.2407 |
MCF 10A | Trametinib | 1.11 | uM | LJP5 | 72 | hr | 1694 | 3255 | 11103 | 0.2932 | 0.2722 |
MCF 10A | Trametinib | 3.33 | uM | LJP5 | 72 | hr | 1694 | 3133 | 11103 | 0.2822 | 0.2543 |
MCF 10A | Trametinib | 10 | uM | LJP5 | 72 | hr | 1694 | 3367 | 11103 | 0.3032 | 0.2879 |
MCF 10A | Omipalisib | 0.04 | uM | LJP6 | 72 | hr | 1694 | 2233 | 11217 | 0.1990 | 0.1064 |
MCF 10A | Omipalisib | 0.12 | uM | LJP6 | 72 | hr | 1694 | 1837 | 11217 | 0.1637 | 0.0296 |
MCF 10A | Omipalisib | 0.37 | uM | LJP6 | 72 | hr | 1694 | 1730 | 11217 | 0.1543 | 0.0076 |
MCF 10A | Omipalisib | 1.11 | uM | LJP6 | 72 | hr | 1694 | 1636 | 11217 | 0.1458 | -0.0139 |
MCF 10A | Omipalisib | 3.33 | uM | LJP6 | 72 | hr | 1694 | 1499 | 11217 | 0.1337 | -0.0455 |
MCF 10A | Omipalisib | 10 | uM | LJP6 | 72 | hr | 1694 | 925 | 11217 | 0.0825 | -0.1994 |
MCF 10A | Buparlisib | 0.04 | uM | LJP5 | 72 | hr | 1694 | 11151 | 11103 | 1.0043 | 1.0031 |
MCF 10A | Buparlisib | 0.12 | uM | LJP5 | 72 | hr | 1694 | 10775 | 11103 | 0.9704 | 0.9780 |
MCF 10A | Buparlisib | 0.37 | uM | LJP5 | 72 | hr | 1694 | 9711 | 11103 | 0.8746 | 0.9035 |
MCF 10A | Buparlisib | 1.11 | uM | LJP5 | 72 | hr | 1694 | 5137 | 11103 | 0.4626 | 0.5047 |
MCF 10A | Buparlisib | 3.33 | uM | LJP5 | 72 | hr | 1694 | 1798 | 11103 | 0.1620 | 0.0218 |
MCF 10A | Buparlisib | 10 | uM | LJP5 | 72 | hr | 1694 | 615 | 11103 | 0.0554 | -0.3121 |
MCF 10A | XL147 | 0.04 | uM | LJP5 | 72 | hr | 1694 | 11313 | 11103 | 1.0189 | 1.0138 |
MCF 10A | XL147 | 0.12 | uM | LJP5 | 72 | hr | 1694 | 10818 | 11103 | 0.9743 | 0.9809 |
MCF 10A | XL147 | 0.37 | uM | LJP5 | 72 | hr | 1694 | 10465 | 11103 | 0.9425 | 0.9568 |
MCF 10A | XL147 | 1.11 | uM | LJP5 | 72 | hr | 1694 | 10115 | 11103 | 0.9110 | 0.9325 |